Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-05 Option Award | 2023-08-23 4:05 pm | 2023-07-05 2026-07-05 | Propanc Biopharma Inc. | PPCB | ZELINGER JOSEF Director | 15,000,000 | $0 | 15,002,805 (Indirect) | View |
| 2021-08-17 Option Award | 2021-08-20 06:15 am | N/A N/A | Propanc Biopharma Inc. | PPCB | Kenyon Julian Norman Chief Scientific Officer | 3,420,000 | $0 | 3,420,005 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-20 06:15 am | N/A N/A | Propanc Biopharma Inc. | PPCB | Nathanielsz James Andrew CEO/CFO | 8,728,000 | $0 | 2,800,000 (Indirect) | View |
Ownership | 2021-08-20 06:14 am | N/A N/A | Propanc Biopharma Inc. | PPCB | ZELINGER JOSEF Director | 0 | $0 | 2,800,000 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-22 9:00 pm | N/A N/A | Propanc Biopharma Inc. | PPCB | Kenyon Julian Norman Chief Scientific Officer | 29,250,000 | $0 | 29,250,000 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-17 07:00 am | N/A N/A | Propanc Biopharma Inc. | PPCB | Nathanielsz James Andrew CEO, Acting CFO, Chairman | 58,500,000 | $0 | 58,500,000 (Direct) | View |